Moderna Inc MRNA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 12:50 PM EDT
175.32quote price arrow up+4.14 (+2.42%)
Volume
3,363,014
52 week range
115.61 - 464.85
Loading...
  • Open172.85
  • Day High179.33
  • Day Low171.85
  • Prev Close171.18
  • 52 Week High464.85
  • 52 Week High Date09/10/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22

Key Stats

  • Market Cap68.587B
  • Shares Out391.20M
  • 10 Day Average Volume5.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.60
  • YTD % Change-30.59

KEY STATS

  • Open172.85
  • Day High179.33
  • Day Low171.85
  • Prev Close171.18
  • 52 Week High464.85
  • 52 Week High Date09/10/21
  • 52 Week Low115.61
  • 52 Week Low Date06/13/22
  • Market Cap68.587B
  • Shares Out391.20M
  • 10 Day Average Volume5.22M
  • Dividend-
  • Dividend Yield-
  • Beta1.60
  • YTD % Change-30.59

RATIOS/PROFITABILITY

  • EPS (TTM)32.80
  • P/E (TTM)5.34
  • Fwd P/E (NTM)8.90
  • EBITDA (TTM)15.945B
  • ROE (TTM)113.86%
  • Revenue (TTM)22.995B
  • Gross Margin (TTM)82.29%
  • Net Margin (TTM)61.12%
  • Debt To Equity (MRQ)4.24%

EVENTS

  • Earnings Date11/02/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Related Video

VIDEO10:0010:00
Coinbase, Airbnb, and Uber are today's picks: Pro Market Movers August 4

Profile

MORE
Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...
Noubar Afeyan Ph.D.
Non-Executive Independent Chairman of the Board, Co-Founder
Stephane Bancel
Chief Executive Officer, Director
Stephen Hoge M.D.
President
David Meline
Chief Financial Officer
Juan Andres
Chief Technical Operations and Quality Officer
Address
200 Technology Sq
Cambridge, MA
02139-3578
United States

Top Peers

SYMBOLLASTCHG%CHG
REGN
Regeneron Pharmaceuticals Inc
635.00+6.29+1.00%
BNTX
BioNTech SE
162.49+2.14+1.33%
BIIB
Biogen Inc
220.45-0.54-0.24%
ILMN
Illumina Inc
227.54+19.22+9.22%
ALNY
Alnylam Pharmaceuticals Inc
230.15-3.70-1.58%